PARP2 and breast carcinoma: Of particular note, in breast cancer, inhibition of poly ADP-ribose polymerase 2 (PARP2) increases the risk of bone metastasis, as this leads to an increase in immature myeloid cells in the bone marrow, which inhibits Th cell recruitment and creates an immunosuppressive microenvironment (42).